Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 03, 2025

Get In Touch

Dapagliflozin and Sitagliptin FDC: Exploring Early Initiation Benefits In Young Newly Diagnosed T2D in India Diabetes and Endocrinology

Dapagliflozin and Sitagliptin FDC: Exploring Early Initiation Benefits In Young Newly Diagnosed T2D in India

  • 01 November 2025
  • 2 days ago

DAa-ViNCI Study: Real-World Data shows Efficacy of Vildagliptin- Dapagliflozin FDC among High-CV Risk T2D in Indian Cardiology Settings Diabetes and Endocrinology

DAa-ViNCI Study: Real-World Data shows Efficacy of Vildagliptin- Dapagliflozin FDC among High-CV Risk T2D in Indian Cardiology Settings

  • 13 October 2025
  • 3 weeks ago

Real-World Case Insight: Triple FDC Therapy in a Young Diabetes Patient - Dr Naresh Kumar Diabetes and Endocrinology

Real-World Case Insight: Triple FDC Therapy in a Young Diabetes Patient - Dr Naresh Kumar

  • 01 October 2025
  • 1 month ago

NPPA Fixes Retail Prices of 9 Formulations Including Dapagliflozin, Sitagliptin, Aceclofenac FDCs, Details Pharma News

NPPA Fixes Retail Prices of 9 Formulations Including Dapagliflozin, Sitagliptin, Aceclofenac FDCs, Details

  • 17 September 2025
  • 1 month ago

Eris Lifesciences Secures CDSCO Panel Nod to Conduct BE Study on Dapagliflozin, Pioglitazone, Metformin FDC Pharma News

Eris Lifesciences Secures CDSCO Panel Nod to Conduct BE Study on Dapagliflozin, Pioglitazone, Metformin FDC

  • 15 September 2025
  • 1 month ago

AstraZeneca's Proposal to Increase Sample Size in Zibotentan-Dapagliflozin Global Trial Gets SEC Nod Pharma News

AstraZeneca's Proposal to Increase Sample Size in Zibotentan-Dapagliflozin Global Trial Gets SEC Nod

  • 14 September 2025
  • 1 month ago

Dapagliflozin Reduces Diabetes and Heart Failure Risk Post-MI, Especially in Prediabetic and Obese Patients: Study Medicine

Dapagliflozin Reduces Diabetes and Heart Failure Risk Post-MI, Especially in Prediabetic and Obese Patients: Study

  • 11 September 2025
  • 1 month ago

Dapagliflozin and Empagliflozin Shows Comparable Effectiveness in Type 2 Diabetes: Study Diabetes and Endocrinology

Dapagliflozin and Empagliflozin Shows Comparable Effectiveness in Type 2 Diabetes: Study

  • 10 September 2025
  • 1 month ago

Bexagliflozin Found As Effective As Dapagliflozin For Glycemic Control In Diabetes: Study Diabetes and Endocrinology

Bexagliflozin Found As Effective As Dapagliflozin For Glycemic Control In Diabetes: Study

  • 05 August 2025
  • 2 months ago

Recent News

Nanotechnology Reverses Alzheimer's Symptoms in Mi...

  • 03 November, 2025

Gum disease could silently cause serious brain dam...

  • 03 November, 2025

Can Early-Day Fasting Significantly Boost Metaboli...

  • 03 November, 2025

Delhi HC bars doctor from running medical centre d...

  • 03 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.